{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T03:55:04Z","timestamp":1791950104785,"version":"4.3.4"},"reference-count":42,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2015,6,4]],"date-time":"2015-06-04T00:00:00Z","timestamp":1433376000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"Key Project of Chinese Ministry of Science and Technology","award":["2012ZX10002007, 2013ZX10002001"],"award-info":[{"award-number":["2012ZX10002007, 2013ZX10002001"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["1171579, 81201287, 81371832"],"award-info":[{"award-number":["1171579, 81201287, 81371832"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2015,8]]},"abstract":"<jats:title>Summary<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Glutathione\u2010S\u2010transferase P1 (<jats:italic><jats:styled-content style=\"fixed-case\">GSTP<\/jats:styled-content>1<\/jats:italic>) methylation has been demonstrated to be associated with oxidative stress induced liver damage in acute\u2010on\u2010chronic hepatitis B liver failure (<jats:styled-content style=\"fixed-case\">ACHBLF<\/jats:styled-content>).<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim<\/jats:title><jats:p>To evaluate the methylation level of <jats:italic><jats:styled-content style=\"fixed-case\">GSTP<\/jats:styled-content>1<\/jats:italic> promoter in acute\u2010on\u2010chronic hepatitis B liver failure and determine its predictive value for prognosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>One hundred and five patients with acute\u2010on\u2010chronic hepatitis B liver failure, 86 with chronic hepatitis B (<jats:styled-content style=\"fixed-case\">CHB<\/jats:styled-content>) and 30 healthy controls (<jats:styled-content style=\"fixed-case\">HC<\/jats:styled-content>) were retrospectively enrolled. <jats:italic><jats:styled-content style=\"fixed-case\">GSTP<\/jats:styled-content>1<\/jats:italic> methylation level in peripheral mononuclear cells (<jats:styled-content style=\"fixed-case\">PBMC<\/jats:styled-content>) was detected by MethyLight. Clinical and laboratory parameters were obtained.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p><jats:italic><jats:styled-content style=\"fixed-case\">GSTP<\/jats:styled-content>1<\/jats:italic> methylation levels were significantly higher in patients with acute\u2010on\u2010chronic hepatitis B liver failure (median 16.84%, interquartile range 1.83\u201359.05%) than those with <jats:styled-content style=\"fixed-case\">CHB<\/jats:styled-content> (median 1.25%, interquartile range 0.48\u20132.47%; <jats:italic>P\u00a0<\/jats:italic>&lt;<jats:italic>\u00a0<\/jats:italic>0.01) and <jats:styled-content style=\"fixed-case\">HC<\/jats:styled-content> (median 0.80%, interquartile range 0.67\u20131.27%; <jats:italic>P\u00a0<\/jats:italic>&lt;<jats:italic>\u00a0<\/jats:italic>0.01). In acute\u2010on\u2010chronic hepatitis B liver failure group, nonsurvivors showed significantly higher <jats:italic><jats:styled-content style=\"fixed-case\">GSTP<\/jats:styled-content>1<\/jats:italic> methylation levels (<jats:italic>P\u00a0<\/jats:italic>&lt;<jats:italic>\u00a0<\/jats:italic>0.05) than survivors. <jats:italic><jats:styled-content style=\"fixed-case\">GSTP<\/jats:styled-content>1<\/jats:italic> methylation level was significantly correlated with total bilirubin (<jats:italic>r<\/jats:italic>\u00a0=\u00a00.29, <jats:italic>P\u00a0<\/jats:italic>&lt;<jats:italic>\u00a0<\/jats:italic>0.01), prothrombin time activity (<jats:italic>r<\/jats:italic>\u00a0=\u00a0\u22120.24, <jats:italic>P\u00a0<\/jats:italic>=<jats:italic>\u00a0<\/jats:italic>0.01) and model for end\u2010stage liver disease (<jats:styled-content style=\"fixed-case\">MELD<\/jats:styled-content>) score (<jats:italic>r<\/jats:italic>\u00a0=\u00a00.26, <jats:italic>P\u00a0<\/jats:italic>=<jats:italic>\u00a0<\/jats:italic>0.01). When used to predict 1\u2010 or 2\u2010month mortality of acute\u2010on\u2010chronic hepatitis B liver failure, <jats:italic><jats:styled-content style=\"fixed-case\">GSTP<\/jats:styled-content>1<\/jats:italic> methylation showed significantly better predictive value than <jats:styled-content style=\"fixed-case\">MELD<\/jats:styled-content> score [area under the receiver operating characteristic curve (<jats:styled-content style=\"fixed-case\">AUC<\/jats:styled-content>) 0.89 vs. 0.72, <jats:italic>P\u00a0<\/jats:italic>&lt;<jats:italic>\u00a0<\/jats:italic>0.01; <jats:styled-content style=\"fixed-case\">AUC<\/jats:styled-content> 0.83 vs. 0.70, <jats:italic>P\u00a0<\/jats:italic>&lt;<jats:italic>\u00a0<\/jats:italic>0.05 respectively]. Meanwhile, patients with <jats:italic><jats:styled-content style=\"fixed-case\">GSTP<\/jats:styled-content>1<\/jats:italic> methylation levels above the cut\u2010off points showed significantly poorer survival than those below (<jats:italic>P\u00a0<\/jats:italic>&lt;<jats:italic>\u00a0<\/jats:italic>0.05).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Aberrant <jats:italic><jats:styled-content style=\"fixed-case\">GSTP<\/jats:styled-content>1<\/jats:italic> promoter methylation exists in acute\u2010on\u2010chronic hepatitis B liver failure and shows high predictive value for short\u2010term mortality. It might serve as a potential prognostic marker for acute\u2010on\u2010chronic hepatitis B liver failure.<\/jats:p><\/jats:sec>","DOI":"10.1111\/apt.13271","type":"journal-article","created":{"date-parts":[[2015,6,4]],"date-time":"2015-06-04T14:07:19Z","timestamp":1433426839000},"page":"319-329","source":"Crossref","is-referenced-by-count":38,"title":["Aberrant <i><scp>GSTP<\/scp>1<\/i> promoter methylation predicts short\u2010term prognosis in acute\u2010on\u2010chronic hepatitis B liver failure"],"prefix":"10.1111","volume":"42","author":[{"given":"S.","family":"Gao","sequence":"first","affiliation":[{"name":"Department of Hepatology Qilu Hospital of Shandong University Jinan China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.\u2010K.","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Hepatology Qilu Hospital of Shandong University Jinan China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.\u2010C.","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Hepatology Qilu Hospital of Shandong University Jinan China"},{"name":"Institute of Hepatology Shandong University Jinan China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.\u2010H.","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Hepatology Qingdao Infectious Disease Hospital Qingdao China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.\u2010H.","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Hepatology Jinan Infectious Disease Hospital Jinan China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.\u2010Y.","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hepatology Qilu Hospital of Shandong University Jinan China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hepatology Qilu Hospital of Shandong University Jinan China"},{"name":"Institute of Hepatology Shandong University Jinan China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,6,4]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-008-9106-x"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0049460"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2007.08.006"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1159\/000047017"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2012.01647.x"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20703"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.11-2-194"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature06745"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng886"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1101\/gr.100289.109"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1159\/000071569"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3130"},{"key":"e_1_2_7_14_1","first-page":"189","article-title":"Epigenetic biomarkers","volume":"355","author":"Chan TA","year":"2012","journal-title":"Curr Top Microbiol Immunol"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.3109\/10409239209082566"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.24.11733"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2011.01438.x"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23190"},{"key":"e_1_2_7_19_1","first-page":"1310","article-title":"Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis","volume":"56","author":"Salerno F","year":"2007","journal-title":"Gut"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.4161\/epi.6.1.13391"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2006.08.008"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/93.22.1747"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gki987"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2013.07.070"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgs201"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.4161\/epi.6.1.13393"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1053\/he.2000.5852"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2004.12.022"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1586\/17474124.2014.906899"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13162"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60723-5"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.22172"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2012.04996.x"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2011.06.052"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0025707"},{"key":"e_1_2_7_36_1","first-page":"1087","article-title":"Silencing of GSTP1 gene by CpG island DNA hypermethylation in HBV\u2010associated hepatocellular carcinomas","volume":"8","author":"Zhong S","year":"2002","journal-title":"Clin Cancer Res"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.03032.x"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2004.01984.x"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1620\/tjem.224.13"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1620\/tjem.228.43"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25706"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2010.08.021"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.2353\/jmoldx.2006.050135"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fapt.13271","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/apt.13271","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T22:56:23Z","timestamp":1695509783000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/apt.13271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,4]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["10.1111\/apt.13271"],"URL":"https:\/\/doi.org\/10.1111\/apt.13271","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,4]]}}}